Immunocore Holdings (IMCR) Return on Invested Capital (2022 - 2025)

Immunocore Holdings (IMCR) has reported Return on Invested Capital for 4 consecutive years, with 0.01% the latest figure, recorded in Q2 2025.

• Quarterly Return on Invested Capital changed N/A year-over-year to 0.01% in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.01% (changed N/A YoY) and the FY2022 annual result came in at 0.0%, up 2.0% from the prior year.
• Return on Invested Capital climbed to 0.01% in Q2 2025 per IMCR's latest filing, from 0.01% in the prior quarter.
• Over the last five years, Return on Invested Capital for IMCR reached as high as 0.0% in Q1 2023 and fell as low as 0.57% in Q1 2024.
• A 4-year average of 0.06% and a median of 0.01% in 2022 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2024 — Return on Invested Capital tumbled 57 bps — and 2025, when it surged 56 bps.
• Year by year, Return on Invested Capital stood at 0.01% in 2022, then tumbled by 43 bps to 0.01% in 2023, then slumped by 93 bps to 0.01% in 2024, then soared by 38 bps to 0.01% in 2025.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.01%, 0.01%, and 0.01% for Q2 2025, Q1 2025, and Q4 2024 respectively.